Toxicity associated with neoadjuvant therapy for borderline resectable pancreatic cancer (BRPC).

被引：0
|
作者：
Beg, M. S. [1 ]
Olowokure, O. O. [1 ]
Ali, S. [1 ]
Ahmad, S. A. [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14670
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14670
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer
    Kumar, Rachit
    Jabbour, Salma K.
    [J]. JOURNAL OF RADIATION ONCOLOGY, 2013, 2 (04) : 353 - 367
  • [2] Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer
    Lee, Sang Hoon
    [J]. KOREAN JOURNAL OF GASTROENTEROLOGY, 2024, 84 (03): : 103 - 110
  • [3] Is Preoperative Chemoradiation Necessary for Borderline Resectable Pancreatic Cancer (BRPC)?: Clinical and Surgical Outcomes Associated with Neoadjuvant FOLFIRINOX Alone in BRPC
    Kim, S. S.
    Ko, A. H.
    Wang, Z. J.
    Kim, G. E.
    Corvera, C. U.
    Harris, H. W.
    Kirkwood, K. S.
    Hirose, R.
    Tempero, M. A.
    Nakakura, E. K.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S165 - S165
  • [4] Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
    Barreto, Savio George
    Shrikhande, Shailesh, V
    Sirohi, Bhawna
    [J]. INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (SUPPL 2) : 249 - 254
  • [5] Strategy of Neoadjuvant Therapy for Resectable/Borderline Resectable Pancreatic Cancer
    Hashimoto, D.
    Satoi, S.
    Yamamoto, T.
    Yamaki, S.
    Hirooka, S.
    Ishida, M.
    Ikeura, T.
    Sekimoto, M.
    [J]. PANCREAS, 2021, 50 (07) : 1064 - 1064
  • [6] Is neoadjuvant chemoradiation important in borderline resectable pancreatic cancer (BRPC)? Clinical and surgical outcomes associated with preoperative FOLFIRINOX alone in BRPC.
    Kim, Sunhee S.
    Nakakura, Eric K.
    Wang, Zhen J.
    Kim, Grace E.
    Corvera, Carlos U.
    Harris, Hobart W.
    Kirkwood, Kimberly S.
    Hirose, Ryutaro
    Tempero, Margaret A.
    Ko, Andrew H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [7] Extended neoadjuvant chemotherapy (CT) in borderline resectable pancreatic cancer (BRPC): Updated results.
    Kanji, Zaheer S.
    Rocha, Flavio G.
    Edwards, Alicia M.
    Mandelson, Margaret T.
    Lin, Bruce S.
    Kozarek, Richard A.
    Rose, J. Bart B.
    Biehl, Thomas R.
    Alseidi, Adnan
    Helton, Scott
    Picozzi, Vincent J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer
    Akhil Chawla
    George Molina
    Linda M. Pak
    Michael Rosenthal
    Joseph D. Mancias
    Thomas E. Clancy
    Brian M. Wolpin
    Jiping Wang
    [J]. Annals of Surgical Oncology, 2020, 27 : 1191 - 1200
  • [9] Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer
    Chawla, Akhil
    Molina, George
    Pak, Linda M.
    Rosenthal, Michael
    Mancias, Joseph D.
    Clancy, Thomas E.
    Wolpin, Brian M.
    Wang, Jiping
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (04) : 1191 - 1200
  • [10] Extended neoadjuvant chemotherapy (CT) in borderline resectable pancreas cancer (BRPC)
    Rose, J. Bart
    Rocha, Flavio G.
    Lin, Bruce S.
    Alseidi, Adnan
    Biehl, Thomas A.
    Moonka, Ravi
    Ryan, John A.
    Traverso, L. William
    Helton, Scott
    Picozzi, Vincent J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345